SCHEMBL6024892

SCHEMBL6024892

CC1(COCCCCCCOc2ccc(C(=O)Oc3ccc(OC(=O)c4ccc(OCCCCCCOCC5(C)COC5)cc4)cc3)cc2)COC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.49
NPC1 O15118 3/20 0.49
NFKB1 P19838 3/20 0.49
NFKB2 Q00653 3/20 0.49
RELA Q04206 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
CYP1A2 P05177 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
PRSS1 P07477 1/20 0.44
ACR P10323 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 3/20 0.43
KMT2A Q03164 2/20 0.43
POLB P06746 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
TSHR P16473 2/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13882235 0.99 LMNA (0.48) LMNANPC1NFKB1NFKB2RELA
SCHEMBL13882247 0.95 LMNA (0.54) LMNANPC1NFKB1NFKB2RELA
SCHEMBL13882233 0.95 LMNA (0.54) LMNANPC1NFKB1NFKB2RELA
SCHEMBL13623372 0.94 KMT2A (0.45) LMNANPC1NFKB1NFKB2RELA
SCHEMBL12288706 0.94 LMNA (0.44) LMNANPC1NFKB1NFKB2RELA
SCHEMBL12926259 0.93 LMNA (0.44) LMNANPC1NFKB1NFKB2RELA
SCHEMBL7152964 0.93 LMNA (0.44) LMNANPC1NFKB1NFKB2RELA
SCHEMBL14099006 0.92 NPC1 (0.43) LMNANPC1NFKB1NFKB2RELA
SCHEMBL14099005 0.92 NPC1 (0.43) LMNANPC1NFKB1NFKB2RELA
SCHEMBL12769757 0.92 NPC1 (0.43) LMNANPC1NFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1337602-B1 POLYMERIZABLE LIQUID CRYSTALLINE DIOXETANES, THEIR PREPARATION AND USE KONINKL PHILIPS ELECTRONICS NV (NL) 2006-04-12 EP disclosed
US-6660344-B2 A crosslinked polyether copolymer for liquid crystalline device; shrinkage inhibition KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) 2003-12-09 US disclosed
US-20030111640-A1 Polymerizable liquid crystalline dioxetanes, their preparation and use KONINKLIJKE PHILIPS ELECTRONICS N.V. 2003-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030111640-A1 Polymerizable liquid crystalline dioxetanes, their preparation and use SCO2, PYM1, CNOT1 LMNA 3633/4885NPC1 4124/4885NFKB1 4493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.